Ümit Ayşe TANDIRCIOĞLU, Nilüfer GÜZOĞLU, Didem ALİEFENDİOĞLU

Management of hyperbilirubinemia in preterm infants in Turkey

Background/aim: Prematurity is a significant risk factor for developing unconjugated hyperbilirubinemia. This study investigated the current approach to managing hyperbilirubinemia in preterm newborns in Turkey. Materials and methods: A study-specific questionnaire on the management of jaundice in preterm infants was sent to 100 level III neonatal intensive care units in Turkey. Results: Responses were obtained from 84 centers from all regions of Turkey. Of the centers, 75.3% used the Turkish Neonatology Society guidelines for deciding to start phototherapy, and 24.7% used different guidelines. The monitoring of bilirubin varied among the participants. Of the participants, 53.6% believed that prophylactic phototherapy was necessary if the infant s birth weight was below 1000 g. The participants reported 6 cases of kernicterus in preterm infants in recent years. Conclusion: There is no single standard approach for managing neonatal hyperbilirubinemia in preterm infants in Turkey. Prophylactic phototherapy for extremely low birth-weight infants might be added to the guidelines for Turkey.

PDF

___

1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297316.
2. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 2012; 32: 660664.
3. Brites D, Brito MA. Bilirubin toxicity. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the Jaundiced Neonate. 1st ed. New York, NY, USA: McGraw-Hill; 2012. pp. 115143.
4. Türk Neonatoloji Derneği. Tanı ve Tedavi Protokolleri No. 1. Ankara, Turkey: Turk Neonatoloji Derneği Bülteni; 2002 (in Turkish).
5. Çoban A, Türkmen M, Gürsoy T. Yenidoğan Sarılıklarında Yaklaşım, İzlem ve Tedavi Rehberi. Türk Neonatoloji Derneği 2014; 139 (in Turkish).
6. Tiker F, Gulcan H, Kilicdag H, Tarcan A, Gurakan B. Extreme hyperbilirubinemia in newborn infants. Clin Pediatrics 2006; 45: 257261.
7. Katar S, Devecioğlu C, Özel A, Sucaklı I. Assessment of etiology of hyperbilirubinemic newborn had exchange transfusion. Dicle Tıp Dergisi 2006; 33: 174177 (in Turkish with English abstract).
8. Tan İ, Salihoğlu Ö, Demirelli Y, Hatipoğlu S. Clinical and laboratory characteristics and associated risk factors of infants hospitalized in neonatal unit due to indirect hyperbilirubinemia. J Clin Exp Invest 2012; 3: 3843.
9. Bolat F, Uslu S, Bulbul A, Comert S, Can E, Nuhoglu A. Evaluation of term newborns hospitalized in our NICU with the diagnosis of indirect hyperbilirubinemia. J Child 2010; 10: 6974.
10. Ipek I, Bozaykut A. Clinically significant neonatal hyperbilirubinemia: an analysis of 646 cases in Istanbul. J Trop Pediatr 2008; 54: 211213.
11. Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, OShea TM, McDavid GE, Perritt RL, Van Meurs KP, Vohr BR et al. NICHD Neonatal Research Network. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008; 359: 18851896.
12. Lasky RE, Church MW, Orlando MS, Morris BH, Parikh NA, Tyson JE, McDavid GE, Oh W, Stevenson DK, Van Meurs KP et al. The effects of aggressive vs. conservative phototherapy on the brainstem auditory evoked responses of extremely-lowbirth-weight infants. Pediatr Research 2012; 7: 7784.
13. Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, OShea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C et al. Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. J Perinatol 2013; 33: 126133.
14. Bansal A, Jain S, Parmar V, Chawla D. Bilirubin rebound after intensive phototherapy for neonatal jaundice. Indian Pediatr 2010; 47: 607609.
15. Kaplan M, Kaplan E, Hammerman C, Algur N, Bromiker R, Schimmel MS, Eidelman AI. Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child 2006; 1: 3134.